Sex-differences in endotoxemia and trimethylamine N-oxide according to the diet and type 2 diabetes status in coronary heart disease patients: from the CORDIOPREV study.
Saved in:
| Title: | Sex-differences in endotoxemia and trimethylamine N-oxide according to the diet and type 2 diabetes status in coronary heart disease patients: from the CORDIOPREV study. |
|---|---|
| Authors: | Garcia-Fernandez H; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Arenas-Montes J; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Gutierrez-Mariscal FM; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Alcala-Diaz JF; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Allais A; Department for Sustainable Development and Ecological Transition, Unit Biology: Food Health and Environment, Università Piemonte Orientale, Vercelli, Italy., Arenas-de Larriva AP; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Luque-Cordoba D; Department of Analytical Chemistry and Nanochemistry University Institute, University of Cordoba, Cordoba, Spain.; CIBER de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain., Torres-Peña JD; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Romero-Cabrera JL; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Luque RM; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.; Department of Cell Biology, Physiology, and Immunology, University of Cordoba, Cordoba, Spain., Priego-Capote F; Department of Analytical Chemistry and Nanochemistry University Institute, University of Cordoba, Cordoba, Spain.; CIBER de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain., Delgado-Lista J; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Lopez-Miranda J; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Camargo A; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. |
| Source: | Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2025 Oct 21; Vol. 12, pp. 1527406. Date of Electronic Publication: 2025 Oct 21 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653388 Publication Model: eCollection Cited Medium: Print ISSN: 2297-055X (Print) Linking ISSN: 2297055X NLM ISO Abbreviation: Front Cardiovasc Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2297-055X |
|---|---|
| DOI: | 10.3389/fcvm.2025.1527406 |
